Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 401 entries
Sorted by: Best Match Show Resources per page
Galectin-3 Regulates Atrial Fibrillation Remodeling and Predicts Catheter Ablation Outcomes.

JACC. Basic to translational science

Takemoto Y, Ramirez RJ, Yokokawa M, Kaur K, Ponce-Balbuena D, Sinno MC, Willis BC, Ghanbari H, Ennis SR, Guerrero-Serna G, Henzi BC, Latchamsetty R, Ramos-Mondragon R, Musa H, Martins RP, Pandit SV, Noujaim SF, Crawford T, Jongnarangsin K, Pelosi F, Bogun F, Chugh A, Berenfeld O, Morady F, Oral H, Jalife J.
PMID: 27525318
JACC Basic Transl Sci. 2016 Apr;1(3):143-154. doi: 10.1016/j.jacbts.2016.03.003.

OBJECTIVES: To determine whether Gal-3 mediates sustained atrial fibrillation (AF)-induced atrial structural and electrical remodeling and contributes to AF perpetuation.BACKGROUND: Galectin-3 (Gal-3) mediates extracellular matrix remodeling in heart failure, but its role in AF progression remains unexplored.METHODS: We examined...

Cite
Takemoto Y, Ramirez RJ, Yokokawa M, et al. Galectin-3 Regulates Atrial Fibrillation Remodeling and Predicts Catheter Ablation Outcomes. JACC Basic Transl Sci. 2016;1(3):143-154doi: 10.1016/j.jacbts.2016.03.003.
Takemoto, Y., Ramirez, R. J., Yokokawa, M., Kaur, K., Ponce-Balbuena, D., Sinno, M. C., Willis, B. C., Ghanbari, H., Ennis, S. R., Guerrero-Serna, G., Henzi, B. C., Latchamsetty, R., Ramos-Mondragon, R., Musa, H., Martins, R. P., Pandit, S. V., Noujaim, S. F., Crawford, T., Jongnarangsin, K., Pelosi, F., Bogun, F., Chugh, A., Berenfeld, O., Morady, F., Oral, H., & Jalife, J. (2016). Galectin-3 Regulates Atrial Fibrillation Remodeling and Predicts Catheter Ablation Outcomes. JACC. Basic to translational science, 1(3), 143-154. https://doi.org/10.1016/j.jacbts.2016.03.003
Takemoto, Yoshio, et al. "Galectin-3 Regulates Atrial Fibrillation Remodeling and Predicts Catheter Ablation Outcomes." JACC. Basic to translational science vol. 1,3 (2016): 143-154. doi: https://doi.org/10.1016/j.jacbts.2016.03.003
Takemoto Y, Ramirez RJ, Yokokawa M, Kaur K, Ponce-Balbuena D, Sinno MC, Willis BC, Ghanbari H, Ennis SR, Guerrero-Serna G, Henzi BC, Latchamsetty R, Ramos-Mondragon R, Musa H, Martins RP, Pandit SV, Noujaim SF, Crawford T, Jongnarangsin K, Pelosi F, Bogun F, Chugh A, Berenfeld O, Morady F, Oral H, Jalife J. Galectin-3 Regulates Atrial Fibrillation Remodeling and Predicts Catheter Ablation Outcomes. JACC Basic Transl Sci. 2016 Apr;1(3):143-154. doi: 10.1016/j.jacbts.2016.03.003. PMID: 27525318; PMCID: PMC4979747.
Copy Download .nbib Format: NLM
Pilot Study on Visual Function and Fundus Autofluorescence Assessment in Diabetic Patients.

Journal of ophthalmology

Calvo-Maroto AM, Esteve-Taboada JJ, Pérez-Cambrodí RJ, Madrid-Costa D, Cerviño A.
PMID: 26977312
J Ophthalmol. 2016;2016:1287847. doi: 10.1155/2016/1287847. Epub 2016 Feb 10.

Purpose. Evaluate optimized fundus autofluorescence (FAF) imaging in early stages of diabetic retinopathy (DR) and relate findings with conventional colour fundus imaging and visual function in diabetic patients and control subjects. Materials and Methods. FAF and colour images were...

Cite
Calvo-Maroto AM, Esteve-Taboada JJ, Pérez-Cambrodí RJ, et al. Pilot Study on Visual Function and Fundus Autofluorescence Assessment in Diabetic Patients. J Ophthalmol. 2016;2016:1287847doi: 10.1155/2016/1287847.
Calvo-Maroto, A. M., Esteve-Taboada, J. J., Pérez-Cambrodí, R. J., Madrid-Costa, D., & Cerviño, A. (2016). Pilot Study on Visual Function and Fundus Autofluorescence Assessment in Diabetic Patients. Journal of ophthalmology, 20161287847. https://doi.org/10.1155/2016/1287847
Calvo-Maroto, Ana M, et al. "Pilot Study on Visual Function and Fundus Autofluorescence Assessment in Diabetic Patients." Journal of ophthalmology vol. 2016 (2016): 1287847. doi: https://doi.org/10.1155/2016/1287847
Calvo-Maroto AM, Esteve-Taboada JJ, Pérez-Cambrodí RJ, Madrid-Costa D, Cerviño A. Pilot Study on Visual Function and Fundus Autofluorescence Assessment in Diabetic Patients. J Ophthalmol. 2016;2016:1287847. doi: 10.1155/2016/1287847. Epub 2016 Feb 10. PMID: 26977312; PMCID: PMC4764742.
Copy Download .nbib Format: NLM
Synthesis of Polymerizable Cyclodextrin Derivatives for Use in Adhesion-Promoting Monomer Formulations.

Journal of research of the National Institute of Standards and Technology

Bowen RL, Carey CM, Flynn KM, Guttman CM.
PMID: 27504209
J Res Natl Inst Stand Technol. 2009 Feb 01;114(1):1-9. doi: 10.6028/jres.114.001. Print 2009.

The synthesis of the cyclodextrin derivatives reported herein was assisted by extensive literature research together with structure-property relationships derived from three-dimensional molecular modeling. These studies led to the hypothesis that many of the 21 hydroxyl groups on beta-cyclodextrin molecules...

Cite
Bowen RL, Carey CM, Flynn KM, et al. Synthesis of Polymerizable Cyclodextrin Derivatives for Use in Adhesion-Promoting Monomer Formulations. J Res Natl Inst Stand Technol. 2009;114(1):1-9doi: 10.6028/jres.114.001.
Bowen, R. L., Carey, C. M., Flynn, K. M., & Guttman, C. M. (2009). Synthesis of Polymerizable Cyclodextrin Derivatives for Use in Adhesion-Promoting Monomer Formulations. Journal of research of the National Institute of Standards and Technology, 114(1), 1-9. https://doi.org/10.6028/jres.114.001
Bowen, Rafael L, et al. "Synthesis of Polymerizable Cyclodextrin Derivatives for Use in Adhesion-Promoting Monomer Formulations." Journal of research of the National Institute of Standards and Technology vol. 114,1 (2009): 1-9. doi: https://doi.org/10.6028/jres.114.001
Bowen RL, Carey CM, Flynn KM, Guttman CM. Synthesis of Polymerizable Cyclodextrin Derivatives for Use in Adhesion-Promoting Monomer Formulations. J Res Natl Inst Stand Technol. 2009 Feb 01;114(1):1-9. doi: 10.6028/jres.114.001. Print 2009. PMID: 27504209; PMCID: PMC4651609.
Copy Download .nbib Format: NLM
Using physiology to understand climate-driven changes in disease and their implications for conservation.

Conservation physiology

Rohr JR, Raffel TR, Blaustein AR, Johnson PT, Paull SH, Young S.
PMID: 27293606
Conserv Physiol. 2013 Aug 26;1(1):cot022. doi: 10.1093/conphys/cot022. eCollection 2013.

Controversy persists regarding the contributions of climate change to biodiversity losses, through its effects on the spread and emergence of infectious diseases. One of the reasons for this controversy is that there are few mechanistic studies that explore the...

Cite
Rohr JR, Raffel TR, Blaustein AR, et al. Using physiology to understand climate-driven changes in disease and their implications for conservation. Conserv Physiol. 2013;1(1):cot022doi: 10.1093/conphys/cot022.
Rohr, J. R., Raffel, T. R., Blaustein, A. R., Johnson, P. T., Paull, S. H., & Young, S. (2013). Using physiology to understand climate-driven changes in disease and their implications for conservation. Conservation physiology, 1(1), cot022. https://doi.org/10.1093/conphys/cot022
Rohr, Jason R, et al. "Using physiology to understand climate-driven changes in disease and their implications for conservation." Conservation physiology vol. 1,1 (2013): cot022. doi: https://doi.org/10.1093/conphys/cot022
Rohr JR, Raffel TR, Blaustein AR, Johnson PT, Paull SH, Young S. Using physiology to understand climate-driven changes in disease and their implications for conservation. Conserv Physiol. 2013 Aug 26;1(1):cot022. doi: 10.1093/conphys/cot022. eCollection 2013. PMID: 27293606; PMCID: PMC4732440.
Copy Download .nbib Format: NLM
Cerebral Microcirculation during Experimental Normovolaemic Anemia.

Frontiers in neurology

Bellapart J, Cuthbertson K, Dunster K, Diab S, Platts DG, Raffel OC, Gabrielian L, Barnett A, Paratz J, Boots R, Fraser JF.
PMID: 26869986
Front Neurol. 2016 Feb 02;7:6. doi: 10.3389/fneur.2016.00006. eCollection 2016.

Anemia is accepted among critically ill patients as an alternative to elective blood transfusion. This practice has been extrapolated to head injury patients with only one study comparing the effects of mild anemia on neurological outcome. There are no...

Cite
Bellapart J, Cuthbertson K, Dunster K, et al. Cerebral Microcirculation during Experimental Normovolaemic Anemia. Front Neurol. 2016;7:6doi: 10.3389/fneur.2016.00006.
Bellapart, J., Cuthbertson, K., Dunster, K., Diab, S., Platts, D. G., Raffel, O. C., Gabrielian, L., Barnett, A., Paratz, J., Boots, R., & Fraser, J. F. (2016). Cerebral Microcirculation during Experimental Normovolaemic Anemia. Frontiers in neurology, 76. https://doi.org/10.3389/fneur.2016.00006
Bellapart, Judith, et al. "Cerebral Microcirculation during Experimental Normovolaemic Anemia." Frontiers in neurology vol. 7 (2016): 6. doi: https://doi.org/10.3389/fneur.2016.00006
Bellapart J, Cuthbertson K, Dunster K, Diab S, Platts DG, Raffel OC, Gabrielian L, Barnett A, Paratz J, Boots R, Fraser JF. Cerebral Microcirculation during Experimental Normovolaemic Anemia. Front Neurol. 2016 Feb 02;7:6. doi: 10.3389/fneur.2016.00006. eCollection 2016. PMID: 26869986; PMCID: PMC4735869.
Copy Download .nbib Format: NLM
Multiple sclerosis therapy and Epstein-Barr virus antibody titres.

Multiple sclerosis and related disorders

Raffel J, Dobson R, Gafson A, Mattoscio M, Muraro P, Giovannoni G.
PMID: 25876475
Mult Scler Relat Disord. 2014 May;3(3):372-4. doi: 10.1016/j.msard.2013.12.004. Epub 2013 Dec 31.

BACKGROUND: Anti-Epstein-Barr virus (EBV) nuclear antigen-1 (anti-EBNA-1) IgG antibody titres have been found to correlate with MRI and clinical measures of disease activity in MS. Despite being a putative biomarker of disease activity, the effect of disease modifying drugs...

Cite
Raffel J, Dobson R, Gafson A, et al. Multiple sclerosis therapy and Epstein-Barr virus antibody titres. Mult Scler Relat Disord. 2013;3(3):372-4doi: 10.1016/j.msard.2013.12.004.
Raffel, J., Dobson, R., Gafson, A., Mattoscio, M., Muraro, P., & Giovannoni, G. (2014). Multiple sclerosis therapy and Epstein-Barr virus antibody titres. Multiple sclerosis and related disorders, 3(3), 372-4. https://doi.org/10.1016/j.msard.2013.12.004
Raffel, Joel, et al. "Multiple sclerosis therapy and Epstein-Barr virus antibody titres." Multiple sclerosis and related disorders vol. 3,3 (2014): 372-4. doi: https://doi.org/10.1016/j.msard.2013.12.004
Raffel J, Dobson R, Gafson A, Mattoscio M, Muraro P, Giovannoni G. Multiple sclerosis therapy and Epstein-Barr virus antibody titres. Mult Scler Relat Disord. 2014 May;3(3):372-4. doi: 10.1016/j.msard.2013.12.004. Epub 2013 Dec 31. PMID: 25876475.
Copy Download .nbib Format: NLM
Cardiac cobaltism: a rare complication after bilateral metal-on-metal total hip arthroplasty.

Arthroplasty today

Martin JR, Spencer-Gardner L, Camp CL, Stulak JM, Sierra RJ.
PMID: 28326382
Arthroplast Today. 2015 Nov 21;1(4):99-102. doi: 10.1016/j.artd.2015.10.002. eCollection 2015 Dec.

This is one of the first documented cases of metal-on-metal (MoM) total hip arthroplasty cobalt cardiac toxicity that has led to patient death. A 69-year-old female presented to our institution with cardiac failure secondary to cobalt toxicity resulting from...

Cite
Martin JR, Spencer-Gardner L, Camp CL, et al. Cardiac cobaltism: a rare complication after bilateral metal-on-metal total hip arthroplasty. Arthroplast Today. 2015;1(4):99-102doi: 10.1016/j.artd.2015.10.002.
Martin, J. R., Spencer-Gardner, L., Camp, C. L., Stulak, J. M., & Sierra, R. J. (2015). Cardiac cobaltism: a rare complication after bilateral metal-on-metal total hip arthroplasty. Arthroplasty today, 1(4), 99-102. https://doi.org/10.1016/j.artd.2015.10.002
Martin, John R, et al. "Cardiac cobaltism: a rare complication after bilateral metal-on-metal total hip arthroplasty." Arthroplasty today vol. 1,4 (2015): 99-102. doi: https://doi.org/10.1016/j.artd.2015.10.002
Martin JR, Spencer-Gardner L, Camp CL, Stulak JM, Sierra RJ. Cardiac cobaltism: a rare complication after bilateral metal-on-metal total hip arthroplasty. Arthroplast Today. 2015 Nov 21;1(4):99-102. doi: 10.1016/j.artd.2015.10.002. eCollection 2015 Dec. PMID: 28326382; PMCID: PMC4958119.
Copy Download .nbib Format: NLM
Rescue Treatment with Pipeline Embolization for Postsurgical Clipping Recurrences of Anterior Communicating Artery Region Aneurysms.

Interventional neurology

Lin LM, Iyer RR, Bender MT, Monarch T, Colby GP, Huang J, Tamargo RJ, Coon AL.
PMID: 29118790
Interv Neurol. 2017 Oct;6(3):135-146. doi: 10.1159/000460264. Epub 2017 Mar 04.

BACKGROUND: Postsurgical clipping aneurysm recurrences or residuals can be difficult to manage with either traditional open microsurgical approaches or endosaccular coiling. Endoluminal parent vessel reconstruction with flow diversion may be an ideal method for treating these recurrences by avoiding...

Cite
Lin LM, Iyer RR, Bender MT, et al. Rescue Treatment with Pipeline Embolization for Postsurgical Clipping Recurrences of Anterior Communicating Artery Region Aneurysms. Interv Neurol. 2017;6(3):135-146doi: 10.1159/000460264.
Lin, L. M., Iyer, R. R., Bender, M. T., Monarch, T., Colby, G. P., Huang, J., Tamargo, R. J., & Coon, A. L. (2017). Rescue Treatment with Pipeline Embolization for Postsurgical Clipping Recurrences of Anterior Communicating Artery Region Aneurysms. Interventional neurology, 6(3), 135-146. https://doi.org/10.1159/000460264
Lin, Li-Mei, et al. "Rescue Treatment with Pipeline Embolization for Postsurgical Clipping Recurrences of Anterior Communicating Artery Region Aneurysms." Interventional neurology vol. 6,3 (2017): 135-146. doi: https://doi.org/10.1159/000460264
Lin LM, Iyer RR, Bender MT, Monarch T, Colby GP, Huang J, Tamargo RJ, Coon AL. Rescue Treatment with Pipeline Embolization for Postsurgical Clipping Recurrences of Anterior Communicating Artery Region Aneurysms. Interv Neurol. 2017 Oct;6(3):135-146. doi: 10.1159/000460264. Epub 2017 Mar 04. PMID: 29118790; PMCID: PMC5662996.
Copy Download .nbib Format: NLM
Corrigendum: CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses.

Nature

Descours B, Petitjean G, López-Zaragoza JL, Bruel T, Raffel R, Psomas C, Reynes J, Lacabaratz C, Levy Y, Schwartz O, Daniel Lelievre J, Benkirane M.
PMID: 28658234
Nature. 2017 Jun 28;546(7660):686. doi: 10.1038/nature22807.

This corrects the article DOI: 10.1038/nature21710.

Cite
Descours B, Petitjean G, López-Zaragoza JL, et al. Corrigendum: CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses. Nature. 2017;546(7660):686doi: 10.1038/nature22807.
Descours, B., Petitjean, G., López-Zaragoza, J. L., Bruel, T., Raffel, R., Psomas, C., Reynes, J., Lacabaratz, C., Levy, Y., Schwartz, O., Daniel Lelievre, J., & Benkirane, M. (2017). Corrigendum: CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses. Nature, 546(7660), 686. https://doi.org/10.1038/nature22807
Descours, Benjamin, et al. "Corrigendum: CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses." Nature vol. 546,7660 (2017): 686. doi: https://doi.org/10.1038/nature22807
Descours B, Petitjean G, López-Zaragoza JL, Bruel T, Raffel R, Psomas C, Reynes J, Lacabaratz C, Levy Y, Schwartz O, Daniel Lelievre J, Benkirane M. Corrigendum: CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses. Nature. 2017 Jun 28;546(7660):686. doi: 10.1038/nature22807. PMID: 28658234.
Copy Download .nbib Format: NLM
Error induced by the estimation of the corneal power and the effective lens position with a rotationally asymmetric refractive multifocal intraocular lens.

International journal of ophthalmology

Piñero DP, Camps VJ, Ramón ML, Mateo V, Pérez-Cambrodí RJ.
PMID: 26085998
Int J Ophthalmol. 2015 Jun 18;8(3):501-7. doi: 10.3980/j.issn.2222-3959.2015.03.12. eCollection 2015.

AIM: To evaluate the prediction error in intraocular lens (IOL) power calculation for a rotationally asymmetric refractive multifocal IOL and the impact on this error of the optimization of the keratometric estimation of the corneal power and the prediction...

Cite
Piñero DP, Camps VJ, Ramón ML, et al. Error induced by the estimation of the corneal power and the effective lens position with a rotationally asymmetric refractive multifocal intraocular lens. Int J Ophthalmol. 2015;8(3):501-7doi: 10.3980/j.issn.2222-3959.2015.03.12.
Piñero, D. P., Camps, V. J., Ramón, M. L., Mateo, V., & Pérez-Cambrodí, R. J. (2015). Error induced by the estimation of the corneal power and the effective lens position with a rotationally asymmetric refractive multifocal intraocular lens. International journal of ophthalmology, 8(3), 501-7. https://doi.org/10.3980/j.issn.2222-3959.2015.03.12
Piñero, David P, et al. "Error induced by the estimation of the corneal power and the effective lens position with a rotationally asymmetric refractive multifocal intraocular lens." International journal of ophthalmology vol. 8,3 (2015): 501-7. doi: https://doi.org/10.3980/j.issn.2222-3959.2015.03.12
Piñero DP, Camps VJ, Ramón ML, Mateo V, Pérez-Cambrodí RJ. Error induced by the estimation of the corneal power and the effective lens position with a rotationally asymmetric refractive multifocal intraocular lens. Int J Ophthalmol. 2015 Jun 18;8(3):501-7. doi: 10.3980/j.issn.2222-3959.2015.03.12. eCollection 2015. PMID: 26085998; PMCID: PMC4458653.
Copy Download .nbib Format: NLM
Advances in the design and development of oncolytic measles viruses.

Oncolytic virotherapy

Hutzen B, Raffel C, Studebaker AW.
PMID: 27512675
Oncolytic Virother. 2015 Aug 27;4:109-18. doi: 10.2147/OV.S66078. eCollection 2015.

A successful oncolytic virus is one that selectively propagates and destroys cancerous tissue without causing excessive damage to the normal surrounding tissue. Oncolytic measles virus (MV) is one such virus that exhibits this characteristic and thus has rapidly emerged...

Cite
Hutzen B, Raffel C, Studebaker AW. Advances in the design and development of oncolytic measles viruses. Oncolytic Virother. 2015;4:109-18doi: 10.2147/OV.S66078.
Hutzen, B., Raffel, C., & Studebaker, A. W. (2015). Advances in the design and development of oncolytic measles viruses. Oncolytic virotherapy, 4109-18. https://doi.org/10.2147/OV.S66078
Hutzen, Brian, et al. "Advances in the design and development of oncolytic measles viruses." Oncolytic virotherapy vol. 4 (2015): 109-18. doi: https://doi.org/10.2147/OV.S66078
Hutzen B, Raffel C, Studebaker AW. Advances in the design and development of oncolytic measles viruses. Oncolytic Virother. 2015 Aug 27;4:109-18. doi: 10.2147/OV.S66078. eCollection 2015. PMID: 27512675; PMCID: PMC4918395.
Copy Download .nbib Format: NLM
An integrated methodology to forecast the efficiency of nourishment strategies in eroding deltas.

The Science of the total environment

Bergillos RJ, López-Ruiz A, Principal-Gómez D, Ortega-Sánchez M.
PMID: 28954378
Sci Total Environ. 2018 Feb 01;613:1175-1184. doi: 10.1016/j.scitotenv.2017.09.197. Epub 2017 Sep 23.

Many deltas across the globe are retreating, and nearby beaches are undergoing strong erosion as a result. Among soft and prompt solutions, nourishments are the most heavily used. This paper presents an integrated methodology to forecast the efficiency of...

Cite
Bergillos RJ, López-Ruiz A, Principal-Gómez D, et al. An integrated methodology to forecast the efficiency of nourishment strategies in eroding deltas. Sci Total Environ. 2017;613:1175-1184doi: 10.1016/j.scitotenv.2017.09.197.
Bergillos, R. J., López-Ruiz, A., Principal-Gómez, D., & Ortega-Sánchez, M. (2018). An integrated methodology to forecast the efficiency of nourishment strategies in eroding deltas. The Science of the total environment, 6131175-1184. https://doi.org/10.1016/j.scitotenv.2017.09.197
Bergillos, Rafael J, et al. "An integrated methodology to forecast the efficiency of nourishment strategies in eroding deltas." The Science of the total environment vol. 613 (2018): 1175-1184. doi: https://doi.org/10.1016/j.scitotenv.2017.09.197
Bergillos RJ, López-Ruiz A, Principal-Gómez D, Ortega-Sánchez M. An integrated methodology to forecast the efficiency of nourishment strategies in eroding deltas. Sci Total Environ. 2018 Feb 01;613:1175-1184. doi: 10.1016/j.scitotenv.2017.09.197. Epub 2017 Sep 23. PMID: 28954378.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 401 entries